A month in, TrumpRx falls short of president’s grand promises - statnews.com
AI Summary1 min read
TL;DR
A month after launch, TrumpRx fails to meet its ambitious promises, facing legal uncertainties and scrutiny from oversight bodies and Congress.
Tags
TrumpRxprescription drugslegal uncertaintySenate scrutinypharmacy payment
- A month in, TrumpRx falls short of president’s grand promises statnews.com
- Legal uncertainty clouds direct-to-consumer drug program after OIG advisory and Senate scrutiny Reuters
- Prescription Drugs TrumpRx Highlight in SOTU Address Pharmacy Practice News
- TrumpRx Discounts Come With Uncertainty Over Pharmacy Payment (1) Bloomberg Law News
- House E&C Democrats Publish Report on TrumpRx NAVLIN DAILY